Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vasectomy and Risk of Prostate Cancer: A Systematic Review and Meta-analysis.
Baboudjian M, Rajwa P, Barret E, Beauval JB, Brureau L, Créhange G, Dariane C, Fiard G, Fromont G, Gauthé M, Mathieu R, Renard-Penna R, Roubaud G, Ruffion A, Sargos P, Rouprêt M, Ploussard G; Prostate Cancer Committee of the Association Française d'Urologie CC-AFU. Baboudjian M, et al. Among authors: barret e. Eur Urol Open Sci. 2022 May 19;41:35-44. doi: 10.1016/j.euros.2022.04.012. eCollection 2022 Jul. Eur Urol Open Sci. 2022. PMID: 35633829 Free PMC article. Review.
The current status of laparoscopic sacrocolpopexy: a review.
Ganatra AM, Rozet F, Sanchez-Salas R, Barret E, Galiano M, Cathelineau X, Vallancien G. Ganatra AM, et al. Among authors: barret e. Eur Urol. 2009 May;55(5):1089-103. doi: 10.1016/j.eururo.2009.01.048. Epub 2009 Feb 4. Eur Urol. 2009. PMID: 19201521 Review.
Morbidity of focal therapy in the treatment of localized prostate cancer.
Barret E, Ahallal Y, Sanchez-Salas R, Galiano M, Cosset JM, Validire P, Macek P, Durand M, Prapotnich D, Rozet F, Cathelineau X. Barret E, et al. Eur Urol. 2013 Apr;63(4):618-22. doi: 10.1016/j.eururo.2012.11.057. Epub 2012 Dec 13. Eur Urol. 2013. PMID: 23265382
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial.
Azzouzi AR, Vincendeau S, Barret E, Cicco A, Kleinclauss F, van der Poel HG, Stief CG, Rassweiler J, Salomon G, Solsona E, Alcaraz A, Tammela TT, Rosario DJ, Gomez-Veiga F, Ahlgren G, Benzaghou F, Gaillac B, Amzal B, Debruyne FM, Fromont G, Gratzke C, Emberton M; PCM301 Study Group. Azzouzi AR, et al. Among authors: barret e. Lancet Oncol. 2017 Feb;18(2):181-191. doi: 10.1016/S1470-2045(16)30661-1. Epub 2016 Dec 20. Lancet Oncol. 2017. PMID: 28007457 Free article. Clinical Trial.
Surgical method influences specimen margins and biochemical recurrence during radical prostatectomy for high-risk prostate cancer: a systematic review and meta-analysis.
Srougi V, Bessa J Jr, Baghdadi M, Nunes-Silva I, da Costa JB, Garcia-Barreras S, Barret E, Rozet F, Galiano M, Sanchez-Salas R, Cathelineau X. Srougi V, et al. Among authors: barret e. World J Urol. 2017 Oct;35(10):1481-1488. doi: 10.1007/s00345-017-2021-9. Epub 2017 Feb 27. World J Urol. 2017. PMID: 28243789 Review.
Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional Outcomes.
Garcia-Barreras S, Sanchez-Salas R, Sivaraman A, Barret E, Secin F, Nunes-Silva I, Linares-Espinós E, Rozet F, Galiano M, Cathelineau X. Garcia-Barreras S, et al. Among authors: barret e. J Urol. 2018 Jan;199(1):140-146. doi: 10.1016/j.juro.2017.08.076. Epub 2017 Aug 18. J Urol. 2018. PMID: 28823768
[Indications and limits of ablative therapies in prostate cancer].
Sanchez-Salas R, Barret E, Renard-Penna R, Cosset JM, Dell'Oglio P, Battista J, Gangi A, Lang H, Cathelineau X. Sanchez-Salas R, et al. Among authors: barret e. Prog Urol. 2017 Nov;27(15):865-886. doi: 10.1016/j.purol.2017.08.004. Epub 2017 Sep 15. Prog Urol. 2017. PMID: 28918871 Review. French.
207 results